Quick Answer
Dare Bioscience, Inc. reported Total Assets of $32.47 million for fiscal year 2025.
Dare Bioscience, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $32.47M | +46.9% |
| 2024 | $22.10M | +3.8% |
| 2023 | $21.28M | -51.4% |
| 2022 | $43.83M | -21.5% |
| 2021 | $55.81M | +639.1% |
| 2020 | $7.55M | +1.5% |
| 2019 | $7.44M | -4.9% |
| 2018 | $7.83M | -45.1% |
| 2017 | $14.26M | +31862.7% |
| 2016 | $44.6K | -99.9% |
| 2015 | $78.22M | +46.5% |
| 2014 | $53.39M | +682.1% |
| 2013 | $6.83M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.75M | +70.3% | +136.9% |
| June 30, 2025 | $12.98M | -45.0% | -30.3% |
| March 31, 2025 | $18.62M | +43.1% | -15.8% |
| December 31, 2024 | $22.10M | +3.8% | +22.4% |
| September 30, 2024 | $18.06M | -27.9% | -23.5% |
| June 30, 2024 | $23.61M | +1.7% | +81.4% |
| March 31, 2024 | $13.01M | -57.1% | -38.9% |
| December 31, 2023 | $21.28M | -51.4% | -15.1% |
- Dare Bioscience, Inc. showed an increase of +46.9% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Dare Bioscience, Inc.’s total assets has grown by 375.7% (from $6.83 million to $32.47 million).
- The most recent figure is from Dare Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: